FDA Inspection 1233993 — Merck Kommanditgesellschaft auf Aktien
The FDA completed an inspection of Merck Kommanditgesellschaft auf Aktien on July 19, 2024 in Darmstadt. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 19, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Darmstadt (Germany)